Screening and Lead Identification — Epigen Biosciences

At Epigen Biosciences, we approach screening and lead identification as a decision-focused engagement, not a disconnected list of tasks. Before work begins, we clarify the scientific or operational question, the materials and information already available, the constraints that could affect execution, and the evidence your team needs at the end. That alignment lets us build a practical scope for screening and lead identification while keeping the work connected to the broader program.

Our screening and lead identification capabilities

We approach screening and lead identification by defining success before the first activity starts. We use early scoping to build a sharper request, review the proposed approach, and agree what a decision-ready result will look like. The goal is to find and validate tractable starting points with evidence strong enough to guide investment. Our project plan explains how the work will produce evidence for which hits or candidates should advance, be redesigned, or stop, including what will happen if results fall outside expectations. Early alignment on inputs, assumptions, responsibilities, and review gates is often the difference between useful evidence and an expensive activity report. Give our team enough non-confidential context to challenge assumptions, identify dependencies, and recommend a realistic path. We are a drug discovery and development CRO based in San Diego, specializing in epigenetics-driven therapeutic approaches. They offer integrated services including target validation, hit-to-lead optimization, preclinical efficacy studies, and IND-enabling programs, helping clients advance novel small molecule and biologic candidates toward clinical development. This context helps establish potential fit. Final selection should depend on project-specific evidence: the proposed scientific lead, relevant examples, methods, capacity, quality status, and timeline. Share the program context, available evidence, constraints, and the decision deadline. Resolve material gaps before the scope and quotation are finalized. Agree the methods, responsibilities, dependencies, controls, acceptance criteria, review points, and change process in one executable plan. Run the work against named milestones. This work sits within our Pre-Clinical Research capabilities and is coordinated with the wider program context when the scope requires it.

• Assay format, controls, library or modality, and throughput.

How we shape the scope

Our planning process connects scientific intent with day-to-day execution. We define the question to be answered, map available inputs to the proposed work, identify review gates, and agree on deliverable formats. We also establish how exceptions, missing information, and unexpected findings will be escalated. This gives your team visibility into the work while allowing our specialists to apply sound judgment as the project develops.

Working with Epigen Biosciences

We work as an extension of the program team while maintaining clear ownership of actions and decisions. Regular reviews cover completed work, near-term priorities, risks, and information needed from either side. If new evidence changes the best route, we explain the reason, the available alternatives, and the effect on deliverables or timing. The goal is a transparent engagement in which technical detail supports progress instead of obscuring it.

Deliverables built for the next decision

A deliverable is only useful if its structure matches the decision it supports. We therefore align early on content, format, traceability, and the expected level of interpretation. The completed package reflects the activities actually performed and separates results from recommendations where that distinction matters. We walk the team through key findings and open items, making it easier to carry the work into the next experiment, study activity, development stage, or internal governance review.

Planning your screening and lead identification project with Epigen Biosciences

To plan a screening and lead identification project, share the program stage, primary objective, available inputs, known constraints, desired timing, and the decision the work needs to support. We will use that information to frame a focused technical discussion and return a scope that identifies the proposed approach, responsibilities, assumptions, review points, deliverables, and major cost or schedule drivers.